Amgen (AMGN) Short Interest Ratio & Short Volume

Short interest is the volume of Amgen shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 7,590,000 shares of AMGN short. 1.42% of Amgen's shares are currently sold short. Learn More on Amgen's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMGN shares currently have a short interest ratio of 3.0. Learn More on Amgen's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amgen: Mint Tower Capital Management B.V., JPMorgan Chase & Co., Susquehanna International Group LLP, Jane Street Group LLC, Squarepoint Ops LLC, Balyasny Asset Management L.P., Cubist Systematic Strategies LLC, Nomura Holdings Inc., Delta Accumulation LLC, Affinity Asset Advisors LLC, Two Sigma Securities LLC, Group One Trading L.P., BNP Paribas Arbitrage SNC, PEAK6 Investments LLC, Bank of America Corp DE, UBS Group AG, HighTower Advisors LLC, Citigroup Inc., Garda Capital Partners LP, Capula Management Ltd, Mint Tower Capital Management B.V., Capstone Investment Advisors LLC, Mint Tower Capital Management B.V., Wolverine Asset Management LLC, Barclays PLC, Portman Square Capital LLP, Savant Capital LLC, XR Securities LLC, Cutler Group LLC CA, Simplex Trading LLC, IMC Chicago LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.42% of Amgen's floating shares are currently sold short.

Amgen saw a decrease in short interest in May. As of May 15th, there was short interest totaling 7,590,000 shares, a decrease of 0.3% from the previous total of 7,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Amgen currently has issued a total of 534,330,000 shares. Some of Amgen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amgen currently has a public float of 533,100,000 shares.

1.42% of Amgen's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Amgen: Gilead Sciences, Inc. (1.44%), Biogen Inc. (2.06%), Seagen Inc. (3.41%), Moderna, Inc. (5.49%), Medtronic plc (0.80%), Intuitive Surgical, Inc. (0.75%), Sanofi (0.15%), Elevance Health, Inc. (0.78%), Stryker Co. (0.88%), Bristol-Myers Squibb (1.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks.

Short selling AMGN is an investing strategy that aims to generate trading profit from Amgen as its price is falling. AMGN shares are trading up $3.80 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Amgen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMGN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMGN, twice per month. The most recent reporting period available is May, 15 2023.